NCT04509804View on ClinicalTrials.gov

Target Gene Sequencing for Advanced Stage, Relapsed or Refractory Natural Killer/T-cell Lymphoma

CompletedOBSERVATIONAL
Enrollment

26

Participants

Timeline

Start Date

May 10, 2018

Primary Completion Date

September 1, 2019

Study Completion Date

January 1, 2020

Conditions
Lymphoid Neoplasm
Interventions
OTHER

non-interventional

non-interventional

Trial Locations (1)

100021

Mei Dong, Beijing

All Listed Sponsors
lead

Chinese Academy of Medical Sciences

OTHER

NCT04509804 - Target Gene Sequencing for Advanced Stage, Relapsed or Refractory Natural Killer/T-cell Lymphoma | Biotech Hunter | Biotech Hunter